Cardiac Implantable Electronic Device (CIED)
Conditions
Brief summary
The study aims to review the centre experience in previous 20 years to understand clinical course of patients underwent TLE for lead and pocket infection, to better understand prognosis, re-implant indication, timing and strategy, and long term outcomes.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients ≥ 18 years. * Patients who underwent explantation of a single-chamber, dual-chamber, or biventricular pacemaker, or an intracardiac defibrillator, due to pocket infection, lead-related infection, or endocarditis at San Raffaele Hospital between January 2004 and November 2020.
Exclusion criteria
* Lack of active status of follow-up
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Major clinical adverse outcomes | 1 year and 5 years follow up | Cardiovascular mortality |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| need of re-implantation of CIED for patients who underwent TLE | discharge, 1 and 5 years | Eventual re-implantation after TLE, during the sane or a following hospitalization. Timing between TLE and re-implantation |